Elmwood Wealth Management Inc. Increases Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Elmwood Wealth Management Inc. lifted its position in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 7.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 62,191 shares of the company’s stock after buying an additional 4,425 shares during the period. Elmwood Wealth Management Inc.’s holdings in ARK Genomic Revolution ETF were worth $1,464,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Crescent Grove Advisors LLC boosted its stake in shares of ARK Genomic Revolution ETF by 1.6% during the 3rd quarter. Crescent Grove Advisors LLC now owns 28,914 shares of the company’s stock worth $740,000 after acquiring an additional 460 shares in the last quarter. Bridges Investment Management Inc. boosted its stake in shares of ARK Genomic Revolution ETF by 3.8% during the 2nd quarter. Bridges Investment Management Inc. now owns 14,121 shares of the company’s stock worth $332,000 after acquiring an additional 517 shares in the last quarter. National Bank of Canada FI boosted its stake in shares of ARK Genomic Revolution ETF by 28.4% during the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock worth $106,000 after acquiring an additional 920 shares in the last quarter. Brown Miller Wealth Management LLC boosted its stake in shares of ARK Genomic Revolution ETF by 5.5% during the 3rd quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock worth $460,000 after acquiring an additional 933 shares in the last quarter. Finally, Dynamic Advisor Solutions LLC raised its position in shares of ARK Genomic Revolution ETF by 7.8% during the 3rd quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock worth $348,000 after purchasing an additional 989 shares during the last quarter.

ARK Genomic Revolution ETF Price Performance

Shares of ARK Genomic Revolution ETF stock traded down $0.83 during trading on Monday, hitting $24.74. 4,522,846 shares of the company were exchanged. The stock has a fifty day moving average of $24.86 and a 200 day moving average of $25.02.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.